RESEARCH TRIANGLE PARK, N.C. -- NC COIN (North Carolina Center of
Innovation for Nanobiotechnology) is continuing to strengthen its team
of industry leaders looking to accelerate ideas, drive business, and
establish a culture for growth by welcoming Dr. Sharlini Sankaran and
Dr. Steve Greenbaum to the organization’s Advisory Council. The
additions come as COIN marks the completion of its popular, informative
five-week Start Up and Early Stage Legal Series presented in concert
with Shanahan Law Group and the NC Biotechnology Center. “Expanding
access to resources and opportunities like the Legal Series while
gaining insight from respected professionals such as Drs. Sankaran and
Greenbaum helps COIN open the gateway to faster development and
commercialization of ideas, develop innovative K-12 community
programming, and help drive new growth in North Carolina,” Joe Magno,
COIN executive director, said.
Sankaran and Greenbaum join fellow industry,
academic, research, and professional services leaders from across the
state meeting on a quarterly basis to provide guidance and advisement to
the COIN Board of Directors and staff regarding programs and events.
Dr.
Sankaran is an experienced leader with public policy, economic
development, and data management experience. She is Executive Director
of REACH NC, a comprehensive statewide web portal to information on
research expertise and capabilities at North Carolina’s universities and
research institutions. Dr. Sankaran is an active and dedicated
volunteer in K-12 and higher Science and Math education, having been
involved in the Durham Women and Math mentoring program; serving as
judge in the annual North Carolina FIRST Robotics tournament; and
speaking on career development to graduate students and postdocs in the
sciences and engineering.
Dr. Greenbaum runs the Homeland
Security Division of BAI, a government services company, leading diverse
teams of experienced scientists and engineers planning, monitoring, and
ensuring compliance for government-sponsored R&D programs. One of
his roles at BAI is to build and maintain related workforce development
initiatives including internships, consulting projects, and recruiting
engagements with graduate programs in relevant scientific and technical
areas.
Other COIN Advisory Council members include Dr. Amanda
Elam, Galaxy Diagnostics; Dr. Sandra Merkel DeJames, Novozymes; Neal
Fowler, Liquidia Technologies; Jinan Glasgow, Neopatents; Dr. Ginger
Rothrock, RTI International; and Preston Linn, Nirvana Sciences.
Running
from June through the end of July, the Start Up and Early Stage Legal
Series was led by Henry Kopf III of Shanahan Law Group and consisted of
informative, hands-on sessions designed for professionals involved in
startups as well as established businesses and nonprofit organizations.
Topics included Pre-Formation and Formation Issues, Hiring and Doing
Business, Protecting Intellectual Property, Fundraising and Exits, and
International Business Transactions.
In addition to gaining
insights from Kopf -- the holder of four U.S. patents who concentrates
his practice in the areas of business litigation, business advisement,
constitutional takings, administrative law, and technology law --
attendees learned from guest speakers such as David Swintosky of Dunning
Capital, an investment banking and financial consulting services group;
John Hollenbach, former CEO & President of Doe & Ingalls
Management (which was bought by Thermo Fisher); and General David L.
Grange, a 30-year U.S. Army veteran and current president of Osprey
Global Solutions.
This is the second time COIN has presented the
Start Up and Early Stage Legal Series to provide attendees with a solid
baseline of knowledge to enhance and improve their business ventures.
Attendees were presented with the tools needed to build a proper
foundation for their business to prevent future business problems and
minimize damage and distractions such problems can cause in addition to
learning how to better prepare to discuss issues with their legal team
when required.
COIN connects influential business, technology,
and educational professionals; provides forums for sharing information
on new discoveries and important trends; and promotes innovative
technologies to leverage our collective capacity to build a more vibrant
economy. Founding members include Novozymes, Kymanox, Danis, CSC
Leasing Company, Duke Energy, the North Carolina Biotechnology Center,
Applied DNA Sciences, Triad Growth Partners, Total Facility Solutions,
Shanahan Law Group, HP, McDonnell Boehnen Hulbert & Berghoff, Jones
Lang LaSalle, Liquidia Technologies, Xanofi, RTI International, BAI and
Bayer.
For more information on membership contact Karen Shank, Director of Business Development at karens@ncoin.org.
About NC COIN
The
North Carolina Center of Innovation for Nanobiotechnology (NC COIN) was
organized to promote the economic development and application of
nanobiotechnology and related technologies across the State of North
Carolina by promoting innovation and commercialization in the fields of
nanobiotechnology and nanomedicine. For information visit
www.nccoin.org.
No comments:
Post a Comment